For the Inventor, By the Inventor

Enter assignee name

Minnetonka, MN, United States of America

Respicardia, Inc.

USPTO Granted Patents = 18

EPO Patents = 6

Trademarks = 6

Forward Citations = 620

Loading Chart...

Loading Chart...

9 inventors (with patents filed for the assignee):

Mark Gelfand (12 out of 216 patents)

Randy W Westlund (11 out of 100 patents)

Mark C Lynn (6 out of 15 patents)

4. Howard R Levin (6 out of 131 patents)

5. Antonis Panteleon (4 out of 6 patents)

6. Kristofer J James (4 out of 39 patents)

7. Andrew Victor Halpert (4 out of 41 patents)

8. Todd P Goblish (2 out of 15 patents)

9. Howard Levin (1 out of 52 patents)

18 patents: Sort by Forward Citations

1. 10821280 - Medical lead and implantation (2020-11-03),

2. 10603491 - Detecting and treating disordered breathing (2020-03-31),

3. 10543363 - Transvascular medical lead (2020-01-28),

4. 10518090 - System and method to modulate phrenic nerve to prevent sleep apnea (2019-12-31),

5. 10507322 - Medical lead with performed bias (2019-12-17),

6. 10406366 - Transvenous phrenic nerve stimulation system (2019-09-10),

7. 10300270 - Device and method for the treatment of breathing disorders and cardiac disorders (2019-05-28),

8. 9999768 - Respiratory rectification (2018-06-19),

9. 9987488 - Detecting and treating disordered breathing (2018-06-05),

10. 9744351 - Device and method for the treatment of breathing disorders and cardiac disorders (2017-08-29),

11. 9744349 - Medical lead and implantation (2017-08-29),

12. 9468755 - Medical lead with preformed bias (2016-10-18),

13. 9295846 - Muscle and nerve stimulation (2016-03-29),

14. 9199075 - Transvascular medical lead (2015-12-01),

15. 8909341 - Device and method for the treatment of breathing disorders and cardiac disorders (2014-12-09),

Respicardia is a medical technology company dedicated to improving the lives of patients suffering from central sleep apnea (CSA). The company has developed an innovative implantable system called the Remedē System, which works by stimulating the patient's diaphragm to restore natural breathing during sleep. Respicardia's mission is to provide effective and long-term relief for CSA patients, enabling them to achieve better sleep, improved quality of life, and enhanced overall health.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

18 Patents

#33 in Minnetonka, MN

#535 in Minnesota

#17,922 in US

#34,120 in the World

Minnetonka, MN, United States of America

Respicardia, Inc.

Forward Citations = 620

9 inventors:

Mark Gelfand (12 out of 216 patents)

Randy W Westlund (11 out of 100 patents)

Mark C Lynn (6 out of 15 patents)

4. Howard R Levin (6 out of 131 patents)

5. Antonis Panteleon (4 out of 6 patents)

Please report any incorrect information to [email protected]

Loading…